SelectMDx improves prostate biopsy decision-making in urology practices

Go back to SelectMDx improves prostate biopsy decision-making in urology practices
(NASDAQ: MDXH) Delayed: 0.21 --0 (-0%)
Previous Close $0.21    52 Week High $ 
Open $0.22    52 Week Low $ 
Day High $0.22    P/E N/A 
Day Low $0.20    EPS $ 
Volume 367,050